올리고뉴클레오티드 합성 시장 규모, 점유율, 성장 분석 : 제품별, 제품 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Oligonucleotide Synthesis Market size was valued at USD 7.30 Billion in 2024 and is poised to grow from USD 8.57 Billion in 2025 to USD 30.93 Billion by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The growing incidence of chronic diseases globally, coupled with significant investments in medical research and development, is driving the demand for oligonucleotide synthesis. The surge in popularity of precision and personalized medicine is expected to present new business opportunities for synthesis providers. Additionally, the increasing acceptance of gene therapies for various conditions and the expanding applications of oligonucleotides across healthcare sectors will further enhance opportunities for these companies. Advancements in synthesis technologies and a rising focus on nucleic acid-based therapeutics are also projected to contribute to market growth. North America stands out as a leading market due to substantial healthcare research spending, though challenges such as high synthesis costs, complex regulatory frameworks, ethical concerns, and limited manufacturing capacities could hinder demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oligonucleotide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesis Market Segments Analysis

Global Oligonucleotide Synthesis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Oligonucleotide, Reagents and Equipment. Based on Type, the market is segmented into Custom Oligos and Predesigned Oligos. Based on Application, the market is segmented into Therapeutic Applications, Diagnostics, Research and Others. Based on End User, the market is segmented into Academic Research Institutes, Pharmaceutical and Biotechnology Companies,, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oligonucleotide Synthesis Market

Oligonucleotides are essential components in various diagnostic technologies like PCR, qPCR, and next-generation sequencing (NGS), driving a significant demand for early diagnostic solutions. As the healthcare landscape increasingly prioritizes swift and accurate diagnostics, the need for high-quality oligonucleotides is expected to surge. This growing emphasis on early detection is likely to unlock new avenues for growth within the oligonucleotide synthesis market, presenting opportunities for advancements in technology and increased production capabilities. Consequently, the ongoing evolution of diagnostic methodologies further underscores the importance of oligonucleotide synthesis in meeting the rising healthcare needs of the global population.

Restraints in the Global Oligonucleotide Synthesis Market

The Global Oligonucleotide Synthesis market faces constraints primarily due to the high costs associated with producing oligonucleotides, particularly those with high purity or complex structures essential for therapeutic use. Additionally, the expenses related to purification processes and rigorous quality control measures contribute to the overall financial strain. This economic barrier results in limited accessibility for smaller biotechnology companies, which may struggle to invest in the necessary resources to compete effectively in the market. Consequently, the financial limitations hinder innovation and growth opportunities within the oligonucleotide synthesis sector, affecting the overall expansion of the market.

Market Trends of the Global Oligonucleotide Synthesis Market

The Global Oligonucleotide Synthesis market is experiencing a dynamic shift towards the integration of artificial intelligence and automation, significantly transforming synthesis processes. This trend enhances the accuracy and scalability of oligonucleotide production, enabling more precise and efficient manufacturing. Automated synthesizers and AI-driven design tools not only streamline operations but also contribute to substantial cost reductions, making high-quality oligonucleotides more accessible. As research demands grow and applications in genomics and personalized medicine expand, the adoption of these advanced technologies is expected to accelerate, driving innovation and competitive advantage within the sector. Consequently, the market is poised for robust growth propelled by these technological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Oligonucleotide Synthesis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Oligonucleotide
  • DNA
  • Column-based
  • Array-based
  • RNA
  • Technology
  • Column-based
  • Array-based
  • Type
  • Short RNA Oligos (< 65 nt)
  • Long RNA Oligos (> 65 nt)
  • CRISPR (sgRNA)
• Reagents
• Equipment

Global Oligonucleotide Synthesis Market Size by Type & CAGR (2026-2033)

• Market Overview
• Custom Oligos
• Predesigned Oligos

Global Oligonucleotide Synthesis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Therapeutic Applications
• Diagnostics
• Research
• Others

Global Oligonucleotide Synthesis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies,
• Diagnostic Laboratories
• Others

Global Oligonucleotide Synthesis Market Size & CAGR (2026-2033)

• North America (Product, Type, Application, End User)
  • US
  • Canada
• Europe (Product, Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Genomics (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Synthesis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATUM (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Script (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGI-DNA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurogentec (Kaneka) (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCust Europe (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epoch Life Science, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (Azenta Life Sciences) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations